Literature DB >> 20055258

Post-stroke depression.

Iris Zavoreo1, Vanja Basić-Kes, Marijana Bosnar-Puretić, Vida Demarin.   

Abstract

Depression following a stroke, also referred to as post-stroke depression (PSD), has long been recognized as one of the most common complications of stroke. PSD has significant adverse consequences on the recovery of motor and cognitive deficits, as well as on the risk of mortality associated with stroke. The prevalence of PSD varies over time with an apparent peak 3-6 months after stroke and subsequent decline reaching about 50% of the initial rates at one year. The natural course of major depression after stroke has spontaneous remission typically 1 to 2 years after stroke. However, it has also been observed that depression becomes chronic and may persist for more than 3 years following stroke. On the other hand, minor depression appears to be more variable, with both short-term and long-term depression occurring in these patients. Early recognition of PSD symptoms and introduction of pharmacological treatment is of great importance in the reduction of stroke complications and stroke mortality as well as for better functional outcome.

Entities:  

Mesh:

Year:  2009        PMID: 20055258

Source DB:  PubMed          Journal:  Acta Clin Croat        ISSN: 0353-9466            Impact factor:   0.780


  8 in total

1.  Association of serum 25-hydroxyvitamin D with symptoms of depression after 6 months in stroke patients.

Authors:  Wei Yue; Lei Xiang; Ya-Jing Zhang; Yong Ji; Xin Li
Journal:  Neurochem Res       Date:  2014-08-26       Impact factor: 3.996

2.  Association of post stroke depression with social factors, insomnia, and neurological status in Chinese elderly population.

Authors:  Lingru Wang; Yong Tao; Yang Chen; Hua Wang; Huadong Zhou; Xiaoyan Fu
Journal:  Neurol Sci       Date:  2016-04-27       Impact factor: 3.307

3.  The association between serum leptin and post stroke depression: results from a cohort study.

Authors:  Yan-tao Li; Ye Zhao; Hua-jing Zhang; Wen-li Zhao
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

4.  Efficacy of sertraline for post-stroke depression: A systematic review protocol of randomized controlled trial.

Authors:  Zheng-Fa Bai; Liu-Yi Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.

Authors:  Nia M Harris; Rodney Ritzel; Nickolas S Mancini; Yuhang Jiang; Xiang Yi; Devika S Manickam; William A Banks; Alexander V Kabanov; Louise D McCullough; Rajkumar Verma
Journal:  Pharmacol Biochem Behav       Date:  2016-09-13       Impact factor: 3.533

6.  Depression increases stroke hospitalization cost: an analysis of 17,010 stroke patients in 2008 by race and gender.

Authors:  Baqar Husaini; Robert Levine; Linda Sharp; Van Cain; Meggan Novotny; Pamela Hull; Gail Orum; Zahid Samad; Uchechukwu Sampson; Majaz Moonis
Journal:  Stroke Res Treat       Date:  2013-03-10

7.  The Relationship Between Sleep Disturbance and Functional Status in Mild Stroke Patients.

Authors:  Jinil Kim; Yuntae Kim; Kwang Ik Yang; Doh-Eui Kim; Soo A Kim
Journal:  Ann Rehabil Med       Date:  2015-08-25

8.  Does citalopram effectively treat post-stroke depression?: A protocol for systematic review and meta analysis.

Authors:  Jing Hu; Li Ma; Zeng-Ye Yang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.